A Study of Demcizumab Plus Paclitaxel in Subjects With Platinum Resistant Ovarian

NCT01952249 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
20
Enrollment
INDUSTRY
Sponsor class

Stopped Phase 2 portion not initiated, no longer pursuing ovarian cancer indication

Conditions

Interventions

Sponsor

OncoMed Pharmaceuticals, Inc.